74 related articles for article (PubMed ID: 38491201)
21. [Preparation and anti-cancer activity in vitro of curcumin loaded mesoporous silica nanoparticle].
He LL; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(21):4189-93. PubMed ID: 27071254
[TBL] [Abstract][Full Text] [Related]
22. Hybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer.
Liu Y; Huang P; Hou X; Yan F; Jiang Z; Shi J; Xie X; Shen J; Fan Q; Wang Z; Feng N
Int J Nanomedicine; 2019; 14():3311-3330. PubMed ID: 31190795
[No Abstract] [Full Text] [Related]
23. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
[TBL] [Abstract][Full Text] [Related]
24. Curcumin a Natural Phenol and Its Therapeutic Role in Cancer and Photodynamic Therapy: A Review.
Kah G; Chandran R; Abrahamse H
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839961
[TBL] [Abstract][Full Text] [Related]
25. Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer.
Shen C; Yue X; Dai L; Wang J; Li J; Fang Q; Zhi Y; Shi C; Li W
J Cancer Res Clin Oncol; 2023 Feb; 149(2):683-699. PubMed ID: 36436092
[TBL] [Abstract][Full Text] [Related]
26. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.
Tang C; Liu J; Yang C; Ma J; Chen X; Liu D; Zhou Y; Zhou W; Lin Y; Yuan X
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358986
[TBL] [Abstract][Full Text] [Related]
27. A Selenium-Substituted Heptamethine Cyanine Photosensitizer for Near-Infrared Photodynamic Therapy.
Sun J; Feng E; Shao Y; Lv F; Wu Y; Tian J; Sun H; Song F
Chembiochem; 2022 Nov; 23(22):e202200421. PubMed ID: 36149045
[TBL] [Abstract][Full Text] [Related]
28. Cancer treatment and survivorship statistics, 2022.
Miller KD; Nogueira L; Devasia T; Mariotto AB; Yabroff KR; Jemal A; Kramer J; Siegel RL
CA Cancer J Clin; 2022 Sep; 72(5):409-436. PubMed ID: 35736631
[TBL] [Abstract][Full Text] [Related]
29. Molecular Effectors of Photodynamic Therapy-Mediated Resistance to Cancer Cells.
Aniogo EC; George BP; Abrahamse H
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947979
[TBL] [Abstract][Full Text] [Related]
30. Polylactide nanoparticles encapsulating indocyanine green for photothermal therapy of prostate cancer cells.
Güney Akkurt M; Gülsoy M
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102693. PubMed ID: 34921985
[TBL] [Abstract][Full Text] [Related]
31. Near infrared light activated upconversion nanoparticles (UCNP) based photodynamic therapy of prostate cancers: An in vitro study.
Güleryüz B; Ünal U; Gülsoy M
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102616. PubMed ID: 34740839
[TBL] [Abstract][Full Text] [Related]
32. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
[TBL] [Abstract][Full Text] [Related]
33. Liposomal IR-780 as a Highly Stable Nanotheranostic Agent for Improved Photothermal/Photodynamic Therapy of Brain Tumors by Convection-Enhanced Delivery.
Lu YJ; S AT; Chuang CC; Chen JP
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359590
[TBL] [Abstract][Full Text] [Related]
34. Obstacles and opportunities in a forward vision for cancer nanomedicine.
de Lázaro I; Mooney DJ
Nat Mater; 2021 Nov; 20(11):1469-1479. PubMed ID: 34226688
[TBL] [Abstract][Full Text] [Related]
35. Synergy of hypoxia relief and heat shock protein inhibition for phototherapy enhancement.
Zhang G; Cheng W; Du L; Xu C; Li J
J Nanobiotechnology; 2021 Jan; 19(1):9. PubMed ID: 33407570
[TBL] [Abstract][Full Text] [Related]
36. Polyphosphoester-Based Nanocarrier for Combined Radio-Photothermal Therapy of Breast Cancer.
Zhang B; Xu C; Sun C; Yu C
ACS Biomater Sci Eng; 2019 Apr; 5(4):1868-1877. PubMed ID: 33405560
[TBL] [Abstract][Full Text] [Related]
37. Isolation and initial characterization of human glioblastoma cells resistant to photodynamic therapy.
Vilchez ML; Rodríguez LB; Palacios RE; Prucca CG; Caverzán MD; Caputto BL; Rivarola VA; Milla Sanabria LN
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102097. PubMed ID: 33232818
[TBL] [Abstract][Full Text] [Related]
38. The microneedles carrying cisplatin and IR820 to perform synergistic chemo-photodynamic therapy against breast cancer.
Fu JJ; Li CW; Liu Y; Chen MY; Zhang Q; Yu XY; Wu B; Li JX; Du LR; Dang YY; Wu D; Wei MY; Lin ZQ; Lei XP
J Nanobiotechnology; 2020 Oct; 18(1):146. PubMed ID: 33076924
[TBL] [Abstract][Full Text] [Related]
39. Clinical development and potential of photothermal and photodynamic therapies for cancer.
Li X; Lovell JF; Yoon J; Chen X
Nat Rev Clin Oncol; 2020 Nov; 17(11):657-674. PubMed ID: 32699309
[TBL] [Abstract][Full Text] [Related]
40. Oxidative Stress and Photodynamic Therapy of Skin Cancers: Mechanisms, Challenges and Promising Developments.
Allegra A; Pioggia G; Tonacci A; Musolino C; Gangemi S
Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32455998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
